Skip to main content

Tom Picone, Cyril Ducet, Larry Lemanski

Premium
The Licensing Executives Society has elected Tom Picone as president, LES said during its annual meeting last week in Vancouver, BC, Canada.
 
Piccone is currently vice president of strategic alliances for Schering-Plough, and is the first pharmaceutical company executive to be elected to LES’ presidency.
 

 
The Burnham Institute for Medical Research last week said that Cyril Doucet has been appointed vice president of operations and administration for Burnham at Lake Nona in Orlando, Fla.
 
Burnham said that Doucet will be responsible for managing the institute’s operations in Orlando as it prepares to move from its temporary facilities there to its planned permanent campus in Lake Nona, Fla.
 
Prior to joining the institute, Doucet served as vice president, chief administrative officer, and secretary-treasurer at the Trudeau Institute in Saranac Lake, NY. He has also held positions as assistant to the senior vice president of laboratories at the National Research Council in Ottawa, Canada, and vice president of administration and secretary-treasurer at the Paper Research Institute of Canada in Montreal.
 

 
Larry Lemanski has been named senior vice president for research and strategic initiatives at Temple University, Temple announced recently.
 
Lemanski will join Temple from Florida Atlantic University, where he is currently vice president for research, the university’s first, a position he has held for six years. Lemanski will begin his appointment at Temple on Dec. 1, and will oversee all aspects of Temple's research enterprise, including administration of sponsored research; technology transfer and commercialization of the university's intellectual property; research infrastructure; and compliance with federal, state, and university research regulations.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.